People · Operator
Named in public records as an officer, director or promoter · active 2010–2014 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Skinit, Inc. | — | Other | Series C | $83.7M | $97.7M | 2010 |
| DIOMICS Corp | — | Biotechnology | Seed | $2.5M | $15.4M | 2014 |
Paul Buss at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Buss on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Anderson | 1 | 20 |
| John Major | 1 | 9 |
| Robert King | 1 | 7 |
| Patrick McBride | 1 | 5 |
| Edward Jenks | 1 | 3 |
| Kevin Roberts | 1 | 3 |
| Darrin Hegemier | 1 | 2 |
| Kirk Avery | 1 | 2 |
| Jennifer Jordan | 1 | 2 |
| John Medica | 1 | 2 |
| Laurence Franklin | 1 | 2 |
| Phil Clough | 1 | 2 |
| Arthur Molloy | 1 | 1 |
| Jeff Mandell | 1 | 1 |
| James Woodcock | 1 | 1 |
| Kevin Butler | 1 | 1 |
| William Ballard | 1 | 1 |
| John Steel, IV | 1 | 1 |
| John Radak | 1 | 1 |
| John Grimstad | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.